After analyzing the database with pathogenic mutations most frequently identified in BRCA genes and excluding studies with overlapping samples, we can verify that the c.5266dupC mutation in BRCA1 is the most commonly found in Brazil in patients with breast and/or ovarian cancer. This evidence concerns the gene BRCA1 and ovarian carcinoma.